Trials / Sponsors / Vyriad, Inc.
Vyriad, Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients Melanoma, Head and Neck Squamous Cell Carcinoma, Colo-rectal Cancer | Phase 2 | 2020-04-24 |
| Active Not Recruiting | Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Selec Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma | Phase 1 / Phase 2 | 2019-04-09 |
| Completed | Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectom Urothelial Carcinoma | Phase 1 | 2018-07-20 |
| Terminated | Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab Recurrent Non-Small Cell Lung Cancer | Phase 1 | 2017-08-03 |
| Completed | Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid T Malignant Solid Tumour | Phase 1 | 2017-04-17 |